A Study to Evaluate Safety and Efficacy of PHX1149T in Subjects With Type 2 Diabetes Mellitus

PHASE2UnknownINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

April 30, 2007

Study Completion Date

February 29, 2008

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

PHX1149T

Trial Locations (26)

Unknown

Chula Vista

Fullerton

Long Beach

Orange

Kissimmee

Melbourne

Bloomington

Wichita

Kansas City

Henderson

Las Vegas

Trenton

Charlotte

Winston-Salem

Cincinnati

Medford

Westminster

Columbia

Dallas

San Antonio

Salt Lake City

Norfolk

Multiple Cities

Mutiple Cities

Mutiple Cities

Mutiple Cities

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Phenomix

INDUSTRY